10results about How to "Accurate medication" patented technology

The invention provides a kit and a method for simultaneously detecting 11 pathogens of a urogenital system and application, and belongs to the field of molecular biology. The primer group is used for detecting urogenital tract pathogens, and the urogenital tract pathogens comprise ureaplasma urealyticum (UU), chlamydia trachomatis (CT), mycoplasma genitalium (MG), ureaplasma parvum (UP), mycoplasma hominis (MH), adenovirus (ADV), trichomonas vaginalis (TV), herpes simplex virus type I (HSV-I), herpes simplex virus type II (HSV-II), haemophilus influenzae (HI) and neisseria gonorrhoeae (NG). The primer group is used for multi-joint detection of non-gonococcal urethritis related pathogens, has high specificity and sensitivity, is adaptive to non-invasive urine specimens, and supports home self-sampling. The kit is used for clinical diagnosis and can quickly judge pathogen types. Precise medication is performed based on a detection result, the healing time of a patient is shortened, the burden of a doctor is relieved, and meanwhile the pathogen transmission risk is reduced.

The invention provides a rapid drug sensitivity detection kit for a breeding site, and belongs to the technical field of drug sensitivity detection. By preparing the penaeus vannamei polypeptide and adding the penaeus vannamei polypeptide into the casein tryptone liquid culture medium, the penaeus vannamei polypeptide has a remarkable promotion effect on the growth of common vibrio parahaemolyticus, vibrio harveyi and edwardsiella tarda in aquaculture, and the bacterial culture time can be shortened. The penaeus vannamei polypeptide is added into a drug sensitivity detection solution to be matched with a triphenyltetrazole chloride color developing agent and a drug sensitivity piece detection system, the prepared rapid drug sensitivity detection kit is used for drug sensitivity detection of clinical diseased prawn samples, and the drug sensitivity detection result can be judged only within 5 hours. The result judgment time is 4 hours earlier than that of a common drug sensitivity detection kit without the prawn polypeptide, and the problem of on-site rapid drug sensitivity detection of an aquaculture farm can be solved.

The throat drug delivery device comprises a drug storage cylinder, one end of the drug storage cylinder is in threaded connection with a dismounting cap, one end, away from the drug storage cylinder, of the dismounting cap is fixedly connected with a silica gel drug delivery tube, the other end of the drug storage cylinder is provided with a boosting structure, and the surface of the drug storage cylinder is provided with a drug delivery depth adjusting structure. The dosing depth adjusting structure comprises a spring clamping sleeve installed on the surface of the medicine storage barrel in a sliding mode, the surface of the spring clamping sleeve is sleeved with a conical barrel, one end of the conical barrel is in threaded connection with a locking nut, and the other end of the conical barrel is fixedly connected with a silica gel mouthpiece. Compared with the prior art, the throat administration device for the respiratory medicine department has the advantages that the depth of the silica gel administration tube penetrating into the oral cavity of a patient can be controlled by the administration depth adjusting structure, the silica gel administration tube is prevented from stabbing the throat of the patient, and meanwhile, after the patient holds the silica gel mouthpiece, the lips are in a closed state, and the patient can inhale by the nose; and the problem that the medicine powder enters the airway of the patient and chokes the patient is avoided.

The application provides a molecular marker for evaluating the prognosis of cervical squamous cell carcinoma and adenocarcinoma and application thereof, and belongs to the technical field of biological detection. Through bioinformatics analysis methods such as multivariate statistical analysis, difference screening, single factor COX regression analysis and multi-factor COX regression analysis, the application obtains an adenine kinase 4 used for evaluating the prognosis marker of cervical squamous cell carcinoma and a brain sponge-shaped deformity 2 protein used for evaluating the prognosis biomarker of cervical adenocarcinoma. Based on the biomarkers of the application, a kit for evaluating cervical squamous cell carcinoma or adenocarcinoma is constructed, which is used for accurately evaluating the prognosis of cervical squamous cell carcinoma or adenocarcinoma.

The invention discloses a NaPi2b extracellular domain antigen protein fragment as well as a preparation method and application thereof, according to a pre-designed amino acid sequence shown as SEQ ID NO: 1, escherichia coli codon optimization is performed, then a target gene is synthesized, and the gene sequence is shown as SEQ ID NO: 2; the gene segment is inserted into an expression plasmid between the NdeI and the HindIII; and carrying out plasmid transformation and screening, protein induced expression and protein purification to prepare the antigen protein fragment. The antigen fragment can be used for generating a corresponding NaPi2b antibody through animal immune response, and the antibody can be used for detecting the expression condition of NaPi2b protein in a human tissue sample by an immunohistochemical method, and is also used for an accompanying diagnostic kit of a humanized NaPi2b antibody coupling medicine, so that the aim of assisting in precise medication is fulfilled.

The application discloses a ventricular support drainage device, which comprises a drainage tube, a self-expanding support bracket, a delivery tube and a support strip. The self-expanding support bracket is arranged outside the drainage tube, and the support bracket in an expanded state is used for supporting the ventricular wall. A small protrusion is arranged inside the support bracket, and the small protrusion is in close contact with the drainage tube in a compressed state. The delivery tube is sleeved outside the drainage tube and the support bracket, and is used for maintaining the drainage tube and the support bracket in the compressed state. The support strip is arranged inside the drainage tube in the compressed state, and is used for supporting the whole structure during delivery. The support strip is used for delivering the drainage tube and the support bracket compressed in the delivery tube to a drainage position under the support of the support strip, and maintaining the position of the drainage tube unchanged when the delivery tube is withdrawn. The support strip is blocked at the first end of the drainage tube. The arrangement guarantees that the drainage device is effectively delivered, and the support bracket plays a supporting role and the drainage tube plays a drainage role after being delivered.

The utility model provides an intravenous medication pipeline arrangement fixer, which relates to the technical field of medication pipeline arrangement, and comprises a fixed box body and a label box, the fixed box body is rotatably connected with a fixed box cover, the fixed box body is provided with a plurality of clamping grooves, and the clamping grooves are used for placing medication pipelines. According to the utility model, through the fixed box body and the fixed box cover, the medication pipelines are respectively placed in the clamping grooves, the label cards are placed in the placing grooves on the inner side of the fixed box cover, the fixed box cover is turned over, the medication pipelines are fixed in the clamping grooves, and medical personnel judge the specific medication types of the medication pipelines according to the label contents on the label cards; and a nurse can conveniently and accurately position in time, so that the purpose of accurately taking medicine is achieved, and the operation is quicker and more orderly.

The present invention discloses a data processing method, a smart wrist-worn device, and a computer-readable storage medium, wherein the method comprises: based on the reminder time of the medication reminder information, outputting the prompt information corresponding to the medication reminder information, wherein the prompt information comprises at least one of vibration prompt information, voice prompt information, or image prompt information; if the chip information corresponding to the medication reminder information is read, then stop outputting the prompt information, wherein the chip information comprises the drug information corresponding to the medication reminder information. The present invention outputs vibration prompt information through the smart wrist-worn device to timely remind the elderly user to take medication, and the chip information can ensure that the user takes medication accurately, avoiding the problem of the elderly user forgetting or taking medication incorrectly, thereby improving the user experience.

The invention provides a composition for treating blood glucose rise caused by SARS-CoV-2 infection, a preparation method, application and a medicine, and relates to the field of pharmaceutical compositions. The composition is prepared from the following components in parts by weight: 10 to 40 parts of rheum emodin, 15 to 60 parts of magnolol, 2.5 to 10 parts of quercetin, 10 to 40 parts of acanthochalcone and 10 to 20 parts of formononetin. The composition has the effect of treating blood glucose rise caused by SARS-CoV-2 infection, and OGTT and ITT experiment results show that the composition can significantly improve fasting blood glucose and glucose tolerance of mice, effectively reduce adverse effects of SARS-CoV-2 infection on an endocrine system and improve the living quality of patients.

This invention discloses nucleic acid aptamers, kits, and applications that specifically bind to sodium valproate small molecules, including the nucleotide sequence shown in SEQ ID No. 1; or, a nucleotide sequence with high homology to the nucleotide sequence of SEQ ID No. 1 and capable of specifically binding to sodium valproate small molecules; or a nucleotide sequence derived from the nucleotide sequence shown in SEQ ID No. 1 capable of specifically binding to sodium valproate small molecules. This invention screens for high-affinity and high-specificity sodium valproate nucleic acid aptamers, providing a new strategy for sodium valproate detection, replacing traditional methods, reducing costs, and improving the accuracy and reliability of sodium valproate detection results. Utilizing multiple detection platforms, it has significant implications for precision medicine for patients.